Short answer
Celldex Therapeutics, Inc. (CLDX) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Celldex reported second-quarter 2026 financial results on August 6, 2026.
Celldex Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Celldex reported second-quarter 2026 financial results on August 6, 2026
- Full financial results and management commentary are furnished in Exhibit 99.1
- Results announcement provides investors an updated view of Celldex’s financial condition and operating performance
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Celldex Therapeutics, Inc. 8-K filings
Get the next CLDX 8-K as it lands
Follow CLDX for push alerts, or ask the research agent what this filing means.